Comparative biology and pathogenesis of AIDS and hepatitis B viruses: related but different
- PMID: 7888194
- DOI: 10.1089/aid.1994.10.1409
Comparative biology and pathogenesis of AIDS and hepatitis B viruses: related but different
Abstract
AIDS (HIV) and hepatitis B viruses are remarkably similar in their sharing of reverse transcription, in their ancestral origins and common genetic elements, and in their modes of transmission. Both are hypermutable and exist as quasispecies due primarily to errors in reverse transcription, though there is severe restriction in the replicative competence of most hepatitis B mutants. They differ in the lack of an integrase in hepatitis B virus and in their pathogenesis in the infected host. HIV survives mainly by antigenic variability, immune evasion, and impairment of immune function though viral regulatory control elements seek to restrict fatal damage to the host. Hepatitis B virus survives primarily by mutation of e antigen/core genes that directly obviates cytotoxic T cell destruction of infected liver cells, or indirectly limits destruction of infected cells through induction of anergy in the cytotoxic T cell response. Most persons infected with hepatitis B virus recover completely while recovery from HIV infection is rare if ever. Hepatitis B is highly preventable by vaccine while HIV vaccine is still seeking a meaningful immunoprophylactic target. AIDS and hepatitis B represent an extreme example, among the viruses of man, in their close similarities but distinct differences. In depth details and perspectives are presented in this review.
Similar articles
-
Overview: practical insights from comparative immunology and pathogenesis of AIDS, hepatitis B, and measles for developing an HIV vaccine.Vaccine. 1995 Dec;13(18):1733-40. doi: 10.1016/0264-410x(95)00114-g. Vaccine. 1995. PMID: 8701586 Review.
-
Drug-resistant and immune-escape HBV mutants in HIV-infected hosts.Antivir Ther. 2010;15(3 Pt B):493-7. doi: 10.3851/IMP1495. Antivir Ther. 2010. PMID: 20516570 Review.
-
Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications.Vaccine. 2001 Feb 28;19(15-16):1837-48. doi: 10.1016/s0264-410x(00)00364-9. Vaccine. 2001. PMID: 11228353 Review.
-
Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.HIV Med. 2007 Jul;8(5):295-9. doi: 10.1111/j.1468-1293.2007.00473.x. HIV Med. 2007. PMID: 17561875
-
The hepatitis B virus and common mutants.Semin Liver Dis. 2003 Feb;23(1):5-20. doi: 10.1055/s-2003-37587. Semin Liver Dis. 2003. PMID: 12616447 Review.
Cited by
-
Do Blood Group Antigens and the Red Cell Membrane Influence Human Immunodeficiency Virus Infection?Cells. 2020 Mar 31;9(4):845. doi: 10.3390/cells9040845. Cells. 2020. PMID: 32244465 Free PMC article. Review.
-
Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis.BMC Infect Dis. 2018 Nov 14;18(1):564. doi: 10.1186/s12879-018-3506-x. BMC Infect Dis. 2018. PMID: 30428847 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources